<p>COVID-19 vaccines do not belong to any political party, but humanity, National Conference leader Omar Abdullah said on Saturday, hours after Samajwadi Party chief Akhilesh Yadav termed coronavirus vaccines to be rolled out in the country as "vaccine of the BJP".</p>

<p>Taking to Twitter, the former Jammu and Kashmir chief minister said, "I don't know about anyone else but when my turn comes I'll happily roll up my sleeve &amp; get a COVID vaccine."</p>

<p>The more people get vaccinated, the better it will be for the country and the economy, the National Conference (NC) vice president said.</p>

<p>"No vaccine belongs to any political party, they belong to humanity &amp; the sooner we get vulnerable people vaccinated the better," he tweeted.</p>

<p>While talking to reporters in Lucknow, Yadav, said, "How can I trust the vaccine, which will be used for vaccination by the BJP? We cannot get vaccinated by the BJP's vaccine.</p>

<p>" On Saturday, an expert panel of India's central drug authority recommended granting permission for restricted emergency use of the indigenously developed COVID-19 vaccine Covaxin with certain conditions, a day after giving similar directions for the Oxford COVID-19 vaccine.</p>

<p>The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) had on Friday recommended granting permission for restricted emergency use of Oxford-AstraZeneca vaccine Covishield, being manufactured by the Serum Institute of India.</p>

<p>The NC leader also tweeted that this "virus has been far too disruptive &amp; if a vaccine helps bring about a semblance of normalcy after all the chaos then sign me up."</p>


COVID-19 vaccines do not belong to any political party, but humanity, National Conference leader Omar Abdullah said on Saturday, hours after Samajwadi Party chief Akhilesh Yadav termed coronavirus vaccines to be rolled out in the country as "vaccine of the BJP".

COVID-19 vaccines do not belong to any political party, but humanity, National Conference leader Omar Abdullah said on Saturday, hours after Samajwadi Party chief Akhilesh Yadav termed coronavirus vaccines to be rolled out in the country as "vaccine of the BJP". Taking to Twitter, the former Jammu and Kashmir chief minister said, "I don't know about anyone else but when my turn comes I'll happily roll up my sleeve & get a COVID vaccine." The more people get vaccinated, the better it will be for the country and the economy, the National Conference (NC) vice president said. "No vaccine belongs to any political party, they belong to humanity & the sooner we get vulnerable people vaccinated the better," he tweeted. While talking to reporters in Lucknow, Yadav, said, "How can I trust the vaccine, which will be used for vaccination by the BJP? We cannot get vaccinated by the BJP's vaccine. " On Saturday, an expert panel of India's central drug authority recommended granting permission for restricted emergency use of the indigenously developed COVID-19 vaccine Covaxin with certain conditions, a day after giving similar directions for the Oxford COVID-19 vaccine. The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) had on Friday recommended granting permission for restricted emergency use of Oxford-AstraZeneca vaccine Covishield, being manufactured by the Serum Institute of India. The NC leader also tweeted that this "virus has been far too disruptive & if a vaccine helps bring about a semblance of normalcy after all the chaos then sign me up."

Covid vaccines don't belong to any political party, but humanity: Omar Abdullah on Akhilesh's remark

<p>Samajwadi Party chief and former Uttar Pradesh chief minister Akhilesh Yadav has said that he would not take the Covid vaccine shot approved by Indian government's expert panel, calling it a "vaccine of the BJP".</p>

<p>"I will not take the COVID-19 vaccine at this moment. That too given by Bharatiya Janata Party. How can I trust BJP`s vaccine, not a chance&nbsp;When our government will be formed, everyone will get a free vaccine. We cannot take the BJP vaccine," said Akhilesh Yadav during a press conference here.</p>

<p>Further cornering the Centre over dry run which is being taken across all states and Union Territories, Yadav said, "What is the need for dry dun in the country. This government was eliminating coronavirus by clapping hands and beating utensils. What is the need for such a large cold chain? What is the need for the vaccine?"SP chief`s statement comes after Dr Shekhar Mande, Director General of the Council of Scientific and Industrial Research (CSIR) said the COVID-19 vaccine is safe and would not have adverse effects and urged people not to hesitate to take it.</p>

<p>"I want to assure everyone that the vaccine is very safe. It has cleared all safety trials and there are no adverse effects. People should not hesitate in taking the vaccine," Mande said.</p>

<p>Mande also said, "If Dr Harsh Vardhan said the dry run was a success in four states, which is the most authentic voice of the government. This is a very good development and should set the country on track for vaccination as soon as approval is granted."</p>

<p>According to the Union Health Ministry, the objective of the dry run is to "assess operational feasibility in the use of COVID Vaccine Intelligence Network (Co-WIN) application in a field environment, to test the linkages between planning and implementation and to identify the challenges and guide the way forward prior to actual implementation".&nbsp;</p>

<p><em>(With inputs from agencies)</em></p>


Samajwadi Party chief and former Uttar Pradesh chief minister Akhilesh Yadav has said that he would not take the Covid vaccine shot approved by Indian government's expert panel, calling it a "vaccine of the BJP".

Samajwadi Party chief and former Uttar Pradesh chief minister Akhilesh Yadav has said that he would not take the Covid vaccine shot approved by Indian government's expert panel, calling it a "vaccine of the BJP". "I will not take the COVID-19 vaccine at this moment. That too given by Bharatiya Janata Party. How can I trust BJP`s vaccine, not a chance When our government will be formed, everyone will get a free vaccine. We cannot take the BJP vaccine," said Akhilesh Yadav during a press conference here. Further cornering the Centre over dry run which is being taken across all states and Union Territories, Yadav said, "What is the need for dry dun in the country. This government was eliminating coronavirus by clapping hands and beating utensils. What is the need for such a large cold chain? What is the need for the vaccine?"SP chief`s statement comes after Dr Shekhar Mande, Director General of the Council of Scientific and Industrial Research (CSIR) said the COVID-19 vaccine is safe and would not have adverse effects and urged people not to hesitate to take it. "I want to assure everyone that the vaccine is very safe. It has cleared all safety trials and there are no adverse effects. People should not hesitate in taking the vaccine," Mande said. Mande also said, "If Dr Harsh Vardhan said the dry run was a success in four states, which is the most authentic voice of the government. This is a very good development and should set the country on track for vaccination as soon as approval is granted." According to the Union Health Ministry, the objective of the dry run is to "assess operational feasibility in the use of COVID Vaccine Intelligence Network (Co-WIN) application in a field environment, to test the linkages between planning and implementation and to identify the challenges and guide the way forward prior to actual implementation". (With inputs from agencies)

‘How can I trust BJP’s vaccine?’ Akhilesh Yadav says won’t take Covid shot

<p>Union Minister Prakash Javadekar on Saturday said that Indian government had approved emergency use of AstraZeneca/ Oxford University coronavirus vaccine, also known as Covishield in India. The minister said that the government had given a go-ahead on Friday. The vaccine had also got a go-ahead from expert panel at&nbsp;Central Drugs Standard Control Organization (CDSCO) had given its nod to the vaccine on Friday itself. Javadekar said that India had more than 50 million doses stockpiled.</p>

<p>The vaccine developed by AstraZeneca and Oxford University will be manufactured by Pune-based Serum Institute of India (SII).</p>

<p>As India gears up to take up the challenging task of inoculating millions of people, many Indian states on Saturday conducted dry-runs for vaccination&nbsp;to assess their ability and readiness to administer Covid-19 shots to hundreds of millions of people, including many in remote corners of the country.</p>

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/india-expert-panel-recommends-use-of-astrazeneca-covid-19-vaccine-353889/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>
</div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

<p>&nbsp;</p>

<p>Delhi, Punjab, Haryana along with Gujarat, Andra Pradesh and Assam were among many states and UTs that conducted dry runs for vaccination earlier in the day,&nbsp;aimed at testing the laid out mechanisms for the vaccination roll-out in the health system.</p>

<p>The Centre had directed earlier to conduct a dry run by all state and UTs on January 2 to test the linkages between planning and implementation, and to identify the challenges.</p>

<p><strong>Also Read | <a href="https://www.wionews.com/india-news/indian-panel-recommends-emergency-use-of-astrazeneca-covid-vaccine-with-conditions-353860">Indian panel recommends emergency use of AstraZeneca COVID vaccine with conditions</a></strong></p>

<p>As per the guidelines issued by the Union Ministry of Health and Family Welfare, all states selected their particular areas and districts to hold the dry run exercise at various government medical college, hospitals, medical centres and the community health centres.</p>

<p>While visiting one of dry run centres, Union Health Minister Harsh Vardhan on Saturday said that one crore healthcare workers and two crore frontline workers would be given free vaccine in the first phase of the inoculation drive.</p>

<p>"In the first phase of vaccination, free vaccine will be provided across the nation to most prioritised beneficiaries that include one crore healthcare and 2 crore frontline workers," Vardhan said in a tweet.</p>

<p><strong>(With agency inputs)</strong></p>


Union Minister Prakash Javadekar on Saturday said that Indian government had approved emergency use of AstraZeneca/ Oxford University coronavirus vaccine, also known as Covishield in India.

Union Minister Prakash Javadekar on Saturday said that Indian government had approved emergency use of AstraZeneca/ Oxford University coronavirus vaccine, also known as Covishield in India. The minister said that the government had given a go-ahead on Friday. The vaccine had also got a go-ahead from expert panel at Central Drugs Standard Control Organization (CDSCO) had given its nod to the vaccine on Friday itself. Javadekar said that India had more than 50 million doses stockpiled. The vaccine developed by AstraZeneca and Oxford University will be manufactured by Pune-based Serum Institute of India (SII). As India gears up to take up the challenging task of inoculating millions of people, many Indian states on Saturday conducted dry-runs for vaccination to assess their ability and readiness to administer Covid-19 shots to hundreds of millions of people, including many in remote corners of the country. × Delhi, Punjab, Haryana along with Gujarat, Andra Pradesh and Assam were among many states and UTs that conducted dry runs for vaccination earlier in the day, aimed at testing the laid out mechanisms for the vaccination roll-out in the health system. The Centre had directed earlier to conduct a dry run by all state and UTs on January 2 to test the linkages between planning and implementation, and to identify the challenges. Also Read | Indian panel recommends emergency use of AstraZeneca COVID vaccine with conditions As per the guidelines issued by the Union Ministry of Health and Family Welfare, all states selected their particular areas and districts to hold the dry run exercise at various government medical college, hospitals, medical centres and the community health centres. While visiting one of dry run centres, Union Health Minister Harsh Vardhan on Saturday said that one crore healthcare workers and two crore frontline workers would be given free vaccine in the first phase of the inoculation drive. "In the first phase of vaccination, free vaccine will be provided across the nation to most prioritised beneficiaries that include one crore healthcare and 2 crore frontline workers," Vardhan said in a tweet. (With agency inputs)

Indian government okays emergency use of AstraZeneca COVID vaccine

The Serum Institute of India, world's largest vaccine manufacturer, reiterated that the vaccine developed by AstraZeneca and Oxford university was safe and immunogenic.

India's Serum institute reiterates safety of AstraZeneca vaccine for COVID-19

AstraZeneca has announced that its vaccine candidate has shown an average efficacy of about 70% , The vaccine candidate has been developed along with the Oxford. The potential vaccine against the novel coronavirus maybe around 90 percent effective, the company said citing interim analysis of results from late-stage clinical trials.

Oxford-AstraZeneca coronavirus vaccine shows 70% efficacy

Britain’s AstraZeneca said on Monday its vaccine for the novel coronavirus could be around 90% effective without any serious side effects.

AstraZeneca says COVID-19 vaccine candidate is 70% effective

The Oxford University and British pharmaceutical giant AstraZeneca have announced on Monday that their vaccine for the novel coronavirus could be around 70% effective under one dosing regimen.

Oxford-AstraZeneca COVID-19 vaccine is 70% effective

<p>Britain’s Oxford University on Monday claimed that in some cases, COVID-19 symptoms persist for&nbsp;last way longer than previously thought.</p>

<p>Initial findings from a study suggest that symptoms such as breathlessness, anxiety, fatigue, and depression continue to appear months after contracting the virus. The study is observing the long-term impact of COVID-19.&nbsp;Additionally, scientists found abnormalities in the organs of many coronavirus survivors, and believe that continued inflammation may continue to be a factor for people who had developed COVID-19.</p>

<p><strong>Also read:&nbsp;</strong><a href="http://13.235.153.162/world/coronavirus-worldwide-cases-surpass-40-million-more-than-50-cases-from-us-india-and-brazil-336386" hreflang="en">Coronavirus: Worldwide cases surpass 40 million; more than 50% cases from US, India and Brazil</a></p>

<p>The study has not been peer-reviewed by additional scientists so far, but has been published on the MedRxiv website.</p>

<p>According to the Oxford study, two to three months after developing coronavirus, at least 64 per cent patients suffered breathlessness, while 55 per cent reported fatigue.</p>

<p>Based on MRI scanning, doctors found abnormalities in lungs of 60 per cent people who had contracted COVID-19. Similar anomalies were noticed in the kidneys of 29 per cent patients, in the hearts of 26 per cent patients, and livers of at least 10 per cent.</p>

<p>“These findings underscore the need to further explore the physiological processes associated with Covid-19 and to develop a holistic, integrated model of clinical care for our patients after they have been discharged from hospital,” Betty Raman, a doctor at Oxford’s Radcliffe Department of Medicine, one of the leaders of the research, told Reuters.</p>

<p><strong>Also read:&nbsp;</strong><a href="http://13.235.153.162/world/as-the-coronavirus-surges-a-new-culprit-emerges-pandemic-fatigue-336261" hreflang="en">As the coronavirus surges, a new culprit emerges - pandemic fatigue</a></p>

<p>“The abnormalities detected ... strongly correlated with serum markers of inflammation… This suggests a potential link between chronic inflammation and ongoing organ damage among survivors”, Raman added.</p>

<p>Last week, Britain’s National Institute for Health Research (NIHR) showed prolonged illness and symptoms after COVID-19, referred to as “Long Covid”. It can involve any or all of the symptoms of coronavirus, which could affect various parts of the body.</p>


Britain’s Oxford University on Monday claimed that in some cases, COVID-19 symptoms persist for last way longer than previously thought. Initial findings from a study suggest that symptoms such as breathlessness, anxiety, fatigue, and depression continue to appear months after contracting the virus.

Britain’s Oxford University on Monday claimed that in some cases, COVID-19 symptoms persist for last way longer than previously thought. Initial findings from a study suggest that symptoms such as breathlessness, anxiety, fatigue, and depression continue to appear months after contracting the virus. The study is observing the long-term impact of COVID-19. Additionally, scientists found abnormalities in the organs of many coronavirus survivors, and believe that continued inflammation may continue to be a factor for people who had developed COVID-19. Also read: Coronavirus: Worldwide cases surpass 40 million; more than 50% cases from US, India and Brazil The study has not been peer-reviewed by additional scientists so far, but has been published on the MedRxiv website. According to the Oxford study, two to three months after developing coronavirus, at least 64 per cent patients suffered breathlessness, while 55 per cent reported fatigue. Based on MRI scanning, doctors found abnormalities in lungs of 60 per cent people who had contracted COVID-19. Similar anomalies were noticed in the kidneys of 29 per cent patients, in the hearts of 26 per cent patients, and livers of at least 10 per cent. “These findings underscore the need to further explore the physiological processes associated with Covid-19 and to develop a holistic, integrated model of clinical care for our patients after they have been discharged from hospital,” Betty Raman, a doctor at Oxford’s Radcliffe Department of Medicine, one of the leaders of the research, told Reuters. Also read: As the coronavirus surges, a new culprit emerges - pandemic fatigue “The abnormalities detected ... strongly correlated with serum markers of inflammation… This suggests a potential link between chronic inflammation and ongoing organ damage among survivors”, Raman added. Last week, Britain’s National Institute for Health Research (NIHR) showed prolonged illness and symptoms after COVID-19, referred to as “Long Covid”. It can involve any or all of the symptoms of coronavirus, which could affect various parts of the body.

Abnormalities spotted in lungs of 60% coronavirus patients months later: Oxford University study

<p>Trials have stopped for the vaccine that was touted to be the frontrunner in the global race to combat coronavirus. In spite of being at the front of the race, trials for the vaccine being developed by AstraZeneca with Oxford University were put on hold.</p>

<p>The decision was taken after one of the participants showed serious and adverse reactions during the trials. When the trails were put on hold, they were being held in the US and UK. The participant suffering from the unexplained illness is expected to recover.</p>

<p>The story was first reported by health news website - Stat News</p>

<p>"Standard review process triggered a pause to vaccination to allow review of safety data,” Stat News&nbsp;quoted AstraZeneca spokesperson as saying.</p>

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/gravitas-setback-for-oxfords-covid-19-vaccine-326394/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>
</div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

<p>In May, the US had ordered 300 million doses of the potential vaccine.&nbsp;Earlier this week, Australia announced that it had placed an order for 3.8 million doses with AstraZeneca.&nbsp;</p>

<p>The vaccine race has become highly political. Russian President Vladimir Putin had tested&nbsp;the Sputnik-V on his daughter. It&nbsp;is the vaccine for which there is no trial data available.&nbsp;Then there is China, where Sinovac is injecting its employees and their families with a potential vaccine.&nbsp;Again, it&nbsp;is a vaccine the world knows very little about.</p>

<p>Amidst all these covert trials, the transparency of one vaccine maker comes as a pleasant surprise.</p>

<p>There are still some companies that are not succumbing to political pressure to win the vaccine race. There are still some firms upholding the safety protocols even when political leaders advocate bypassing the critical stages of the trial.</p>

<p>Just yesterday, nine vaccine makers vowed not to cut corners on testing.&nbsp;AstraZeneca was one of the signatories</p>

<p>Others include Bio-N-Tech, Pfizer, Novovax, Sanofi, Glaxo-Smithkline, Johnson &amp; Johnson and Merck</p>

<p>Reacting to paused trials, Australia's Deputy Chief Medical Officer Nick Coatsworth said that the news was a testimony to safety and transparency.</p>

<p>"The fact that we're hearing about it and I'm talking about it, is testimony to the safety and the transparency. Both of which are such critical principles as we continue the race towards an effective COVID-19 vaccine," he said.</p>

<p>British Health Minister Matt Hancock echoed the sentiment.</p>

<p>"Well obviously I'd rather this went completely smoothly. However, we're absolutely clear that safety comes first with the vaccine so there's been a pause while they investigate an incident," he said.</p>

<p>These reactions are not surprising as Australia and UK both have stakes in a potential vaccine.&nbsp;The paused trial is a setback, no matter what British authorities tell you.</p>

<p>The world is in a dire need of a vaccine. The Wuhan virus has already taken 9,00,000 lives but the world needs a vaccine that can save lives, not take more.<br />
&nbsp;</p>


Trials have stopped for the vaccine that was touted to be the frontrunner in the global race to combat coronavirus. In spite of being at the front of the race, trials for the vaccine being developed by AstraZeneca with Oxford University were put on hold.

Trials have stopped for the vaccine that was touted to be the frontrunner in the global race to combat coronavirus. In spite of being at the front of the race, trials for the vaccine being developed by AstraZeneca with Oxford University were put on hold. The decision was taken after one of the participants showed serious and adverse reactions during the trials. When the trails were put on hold, they were being held in the US and UK. The participant suffering from the unexplained illness is expected to recover. The story was first reported by health news website - Stat News "Standard review process triggered a pause to vaccination to allow review of safety data,” Stat News quoted AstraZeneca spokesperson as saying. × In May, the US had ordered 300 million doses of the potential vaccine. Earlier this week, Australia announced that it had placed an order for 3.8 million doses with AstraZeneca. The vaccine race has become highly political. Russian President Vladimir Putin had tested the Sputnik-V on his daughter. It is the vaccine for which there is no trial data available. Then there is China, where Sinovac is injecting its employees and their families with a potential vaccine. Again, it is a vaccine the world knows very little about. Amidst all these covert trials, the transparency of one vaccine maker comes as a pleasant surprise. There are still some companies that are not succumbing to political pressure to win the vaccine race. There are still some firms upholding the safety protocols even when political leaders advocate bypassing the critical stages of the trial. Just yesterday, nine vaccine makers vowed not to cut corners on testing. AstraZeneca was one of the signatories Others include Bio-N-Tech, Pfizer, Novovax, Sanofi, Glaxo-Smithkline, Johnson & Johnson and Merck Reacting to paused trials, Australia's Deputy Chief Medical Officer Nick Coatsworth said that the news was a testimony to safety and transparency. "The fact that we're hearing about it and I'm talking about it, is testimony to the safety and the transparency. Both of which are such critical principles as we continue the race towards an effective COVID-19 vaccine," he said. British Health Minister Matt Hancock echoed the sentiment. "Well obviously I'd rather this went completely smoothly. However, we're absolutely clear that safety comes first with the vaccine so there's been a pause while they investigate an incident," he said. These reactions are not surprising as Australia and UK both have stakes in a potential vaccine. The paused trial is a setback, no matter what British authorities tell you. The world is in a dire need of a vaccine. The Wuhan virus has already taken 9,00,000 lives but the world needs a vaccine that can save lives, not take more.

Trials of Oxford University's COVID-19 vaccine 'paused', what now?

<p>Serum Institute, the Pune-based third largest&nbsp;manufacturer of vaccines in the world has said that it will continue with Covid-19 vaccine trials in India. Serum Institute said that they had not faced any issues. Trials of the same vaccine have be paused in UK after one of the patients developed illness.</p>

<p>"We can't comment much on the UK trials, but they have been paused for further review and they hope to restart soon. As far as Indian trials are concerned, it is continuing &amp; we have faced no issues at all: Serum Institute of India on reports on AstraZeneca halting the trials," Serum Institute was quoted as saying by ANI</p>

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<blockquote class="twitter-tweet">
<p dir="ltr" lang="en">We can't comment much on the UK trials, but they have been paused for further review and they hope to restart soon. As far as Indian trials are concerned, it is continuing &amp; we have faced no issues at all: Serum Institute of India on reports on AstraZeneca halting the trials. <a href="https://t.co/gL7IirfnXy">https://t.co/gL7IirfnXy</a></p>
— ANI (@ANI) <a href="https://twitter.com/ANI/status/1303631201157042176?ref_src=twsrc%5Etfw">September 9, 2020</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

<p>&nbsp;</p>

<p>The vaccine, which is known as Covishield in India, is being develped by Oxford University and AstraZeneca.</p>

<p>AstraZeneca, the pharmaceutical giant, "voluntarily paused" clinical trials of the Coronavirus vaccine after a volunteer developed an unexplained illness. AstraZeneca called it a routine action but this pause in the clinical trials made headlines everywhere. The vaccine, being developed by Oxford University and AstraZeneca is considered to be the frotrunner in the race to develop vaccine against coronavirus.</p>

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="http://13.235.153.162/videos/astrazeneca-covid-19-vaccine-study-paused-after-a-participant-fall-ill-in-uk-326226/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>
</div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

<p>&nbsp;</p>

<p>"As part of the ongoing randomized, controlled global trials of the Oxford coronavirus vaccine, our standard review process was triggered and we voluntarily paused vaccination to allow review of safety data by an independent committee," a spokesperson said earlier on Wednesday.</p>

<p>The company spokesperson also added that in large trials, illnesses will sometimes happen by chance but must be reviewed independently.</p>

<p><strong>Also&nbsp;Read: <a href="https://www.wionews.com/world/astrazeneca-voluntarily-pauses-clinical-trials-for-oxfords-covid-19-vaccine-after-unexplained-illness-326112">AstraZeneca 'voluntarily pauses' clinical trials for Oxford's COVID-19 vaccine after unexplained illness</a></strong><br />
&nbsp;</p>

<p>"We are working to expedite the review of the single event to minimise any potential impact on the trial timeline," the spokesperson said.</p>

<p>The nature and severity of illness or where the patient was not clear immediately.&nbsp;</p>


Serum Institute, the Pune-based third largest manufacturer of vaccines in the world has said that it will continue with Covid-19 vaccine trials in India. Serum Institute said that they had not faced any issues.

Serum Institute, the Pune-based third largest manufacturer of vaccines in the world has said that it will continue with Covid-19 vaccine trials in India. Serum Institute said that they had not faced any issues. Trials of the same vaccine have be paused in UK after one of the patients developed illness. "We can't comment much on the UK trials, but they have been paused for further review and they hope to restart soon. As far as Indian trials are concerned, it is continuing & we have faced no issues at all: Serum Institute of India on reports on AstraZeneca halting the trials," Serum Institute was quoted as saying by ANI We can't comment much on the UK trials, but they have been paused for further review and they hope to restart soon. As far as Indian trials are concerned, it is continuing & we have faced no issues at all: Serum Institute of India on reports on AstraZeneca halting the trials. https://t.co/gL7IirfnXy — ANI (@ANI) September 9, 2020 × The vaccine, which is known as Covishield in India, is being develped by Oxford University and AstraZeneca. AstraZeneca, the pharmaceutical giant, "voluntarily paused" clinical trials of the Coronavirus vaccine after a volunteer developed an unexplained illness. AstraZeneca called it a routine action but this pause in the clinical trials made headlines everywhere. The vaccine, being developed by Oxford University and AstraZeneca is considered to be the frotrunner in the race to develop vaccine against coronavirus. × "As part of the ongoing randomized, controlled global trials of the Oxford coronavirus vaccine, our standard review process was triggered and we voluntarily paused vaccination to allow review of safety data by an independent committee," a spokesperson said earlier on Wednesday. The company spokesperson also added that in large trials, illnesses will sometimes happen by chance but must be reviewed independently. Also Read: AstraZeneca 'voluntarily pauses' clinical trials for Oxford's COVID-19 vaccine after unexplained illness "We are working to expedite the review of the single event to minimise any potential impact on the trial timeline," the spokesperson said. The nature and severity of illness or where the patient was not clear immediately.

Oxford University Covid-19 vaccine trials in India to continue despite 'pause' in UK: Serum Institute

<p>AstraZeneca Plc on Thursday signed a deal with a China-based company for producing its potential drug to treat novel coronavirus in mainland China.&nbsp;</p>

<p>Shenzhen Kangtai Biological Products becomes the first Chinese company to enter into a deal with AstraZeneca.&nbsp;</p>

<p><strong>Also read |&nbsp;<a href="https://www.wionews.com/world/oxford-astrazeneca-coronavirus-vaccine-trial-safe-produced-immune-response-data-reveals-314716">Oxford-AstraZeneca coronavirus vaccine trial: Safe &amp; produced immune response, data reveals</a> &nbsp;</strong></p>

<p>AZD1222, that is jointly developed by AstraZeneca and Oxford Univesity, is one of the frontrunners in COVID-19 vaccine race.</p>

<p><strong>Also read |&nbsp;<a href="https://www.wionews.com/world/brazil-signs-agreement-to-produce-astrazenecas-experimental-covid-19-vaccine-309047">Brazil signs agreement to produce AstraZeneca's experimental COVID-19 vaccine</a></strong></p>

<p>The agreement says that Shenzhen Kangtai will annually produce at least 100 million doses of AZD1222 and must be able to stretch it to 200 million doses by the end of 2021, AstraZeneca said on Thursday.&nbsp;</p>

<p>It also said the two pharma giants will seek the possibility of cooperation on the vaccine candidate in other markets.&nbsp;</p>

<p>Earlier, AstraZeneca has signed production deals with countries like the US, India, Britain, South Korea, which overall leads to the manufacturing of over two billion doses.&nbsp;</p>

<p>Chinese organisations have earlier tied up with other Western pharma firms such as Germany's BioNTech and US's Inovio Pharma for producing coronavirus vaccine.&nbsp;</p>

<p>Shenzhen Kangtai is one of China's leading vaccine makers and its shares have surged nearly 90 per cent to about $20 billion in the last one month, with its stocks witnessing a record-high on Tuesday.<br />
&nbsp;</p>


AstraZeneca Plc on Thursday signed a deal with a China-based company for producing its potential drug to treat novel coronavirus in mainland China. Shenzhen Kangtai Biological Products becomes the first Chinese company to enter into a deal with AstraZeneca.

AstraZeneca Plc on Thursday signed a deal with a China-based company for producing its potential drug to treat novel coronavirus in mainland China. Shenzhen Kangtai Biological Products becomes the first Chinese company to enter into a deal with AstraZeneca. Also read | Oxford-AstraZeneca coronavirus vaccine trial: Safe & produced immune response, data reveals AZD1222, that is jointly developed by AstraZeneca and Oxford Univesity, is one of the frontrunners in COVID-19 vaccine race. Also read | Brazil signs agreement to produce AstraZeneca's experimental COVID-19 vaccine The agreement says that Shenzhen Kangtai will annually produce at least 100 million doses of AZD1222 and must be able to stretch it to 200 million doses by the end of 2021, AstraZeneca said on Thursday. It also said the two pharma giants will seek the possibility of cooperation on the vaccine candidate in other markets. Earlier, AstraZeneca has signed production deals with countries like the US, India, Britain, South Korea, which overall leads to the manufacturing of over two billion doses. Chinese organisations have earlier tied up with other Western pharma firms such as Germany's BioNTech and US's Inovio Pharma for producing coronavirus vaccine. Shenzhen Kangtai is one of China's leading vaccine makers and its shares have surged nearly 90 per cent to about $20 billion in the last one month, with its stocks witnessing a record-high on Tuesday.

AstraZeneca signs first deal with Chinese firm to produce COVID-19 vaccine

<p>Internationally, the race to find coronavirus vaccine is turning into a war.&nbsp;</p>

<p>India, on the other hand is secure in its self-knowledge. Whosoever comes up first in this vaccine race, India will be asked for its mass production.&nbsp;</p>

<p><strong>Also read |&nbsp;<a href="https://www.wionews.com/world/coronavirus-vaccine-wars-us-accuses-russian-hacker-group-apt29-of-trying-to-steal-data-314092">Coronavirus vaccine wars: US accuses Russian hacker group APT29 of trying to steal data</a></strong></p>

<p>One out of the three vaccines produced in the world is made in India. This has put India in a special position, but added great responsibility too.&nbsp;</p>

<p><strong>Also read |&nbsp;<a href="https://www.wionews.com/india-news/indias-cadila-aims-to-complete-trial-of-coronavirus-vaccine-by-march-313985">India's Cadila aims to complete trial of coronavirus vaccine by March</a></strong></p>

<p>Around the world, there are over 140 vaccine candidates and only 11 so far have reached the stage of human trials.&nbsp;</p>

<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/gravitas-india-the-worlds-vaccine-producer-314138/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>

<p>From India, two candidates have made it to the human trials: Bharat Biotech's Covaxin and Zydus Cadila's ZyCoV-D.&nbsp;</p>

<p>India may or may not win this race, but no vaccine would succeed without India.&nbsp;</p>

<p>This is because discovering a vaccine is only half the battle won, the second, an equally important task is to manufacture them in great numbers.&nbsp;</p>

<p>To make vaccine accessible to all countries, mass production would be required with affordable prices.&nbsp;</p>

<p>And this responsibility rests on India's shoulders.&nbsp;</p>

<p>Every year, India produces three billion doses of vaccine and the cost of production and clinical trials are the lowest in the world.&nbsp;</p>

<p>For instance, the vaccine of rotavirus, a gastro-infection that particularly affects children is made 15 times cheaper by India.&nbsp;</p>

<p>The world's largest vaccine manufacturer, Serum Institute of India, makes more than 1.5 billion doses every year and the vaccines are exported to 170 countries.&nbsp;</p>

<p>The institute's role in eradication of polio must also be highlighted.&nbsp;</p>

<p>If Oxford University's COVID-19 vaccine gets a green signal, the company says, in one year, it can produce 700-800 billion doses.&nbsp;</p>

<p>And that too for 13 dollars, the cheapest in the world.&nbsp;</p>

<p>Bill Gates says only India is the country that can produce the vaccine for the entire world.&nbsp;</p>

<p>In April, even China admitted India's pharmaceutical prowess.&nbsp;</p>

<p>Currently, at least six Indian pharmaceutical companies are working with global institutes, which means no just one, but multiple COVID-19 vaccines could be made in India.&nbsp;</p>

<p>To sum it up, the Wuhan virus vaccine, developed anywhere in the world, it will be made in India.&nbsp;</p>

<p><br />
&nbsp;</p>


Internationally, the race to find coronavirus vaccine is turning into a war. India, on the other hand is secure in its self-knowledge. Whosoever comes up first in this vaccine race, India will be asked for its mass production.

Internationally, the race to find coronavirus vaccine is turning into a war. India, on the other hand is secure in its self-knowledge. Whosoever comes up first in this vaccine race, India will be asked for its mass production. Also read | Coronavirus vaccine wars: US accuses Russian hacker group APT29 of trying to steal data One out of the three vaccines produced in the world is made in India. This has put India in a special position, but added great responsibility too. Also read | India's Cadila aims to complete trial of coronavirus vaccine by March Around the world, there are over 140 vaccine candidates and only 11 so far have reached the stage of human trials. From India, two candidates have made it to the human trials: Bharat Biotech's Covaxin and Zydus Cadila's ZyCoV-D. India may or may not win this race, but no vaccine would succeed without India. This is because discovering a vaccine is only half the battle won, the second, an equally important task is to manufacture them in great numbers. To make vaccine accessible to all countries, mass production would be required with affordable prices. And this responsibility rests on India's shoulders. Every year, India produces three billion doses of vaccine and the cost of production and clinical trials are the lowest in the world. For instance, the vaccine of rotavirus, a gastro-infection that particularly affects children is made 15 times cheaper by India. The world's largest vaccine manufacturer, Serum Institute of India, makes more than 1.5 billion doses every year and the vaccines are exported to 170 countries. The institute's role in eradication of polio must also be highlighted. If Oxford University's COVID-19 vaccine gets a green signal, the company says, in one year, it can produce 700-800 billion doses. And that too for 13 dollars, the cheapest in the world. Bill Gates says only India is the country that can produce the vaccine for the entire world. In April, even China admitted India's pharmaceutical prowess. Currently, at least six Indian pharmaceutical companies are working with global institutes, which means no just one, but multiple COVID-19 vaccines could be made in India. To sum it up, the Wuhan virus vaccine, developed anywhere in the world, it will be made in India.

As global vaccine race intensifies, India has a crucial responsibility

<p>The much-awaited COVID-19 vaccine developed by the University of Oxford has raised hopes after Phase one human trials showed some encouraging trends.&nbsp;</p>

<p>Blood samples taken from a group of volunteers who were involved in the study showed the vaccine stimulated antibodies and "killer T-cells", the Daily Telegraph reported.</p>

<p><strong>Also read |&nbsp;<a href="https://www.wionews.com/world/8-world-leaders-demand-equal-global-access-to-coronavirus-vaccine-313620">8 world leaders demand equal global access to coronavirus vaccine</a></strong></p>

<p>Previous research has suggested T-cells can last in the body for years and help combat the viruses.</p>

<p><strong>Also read |&nbsp;<a href="https://www.wionews.com/india-news/indian-pharma-industry-capable-of-producing-covid-19-vaccines-for-entire-world-bill-gates-313652">Indian pharma industry capable of producing COVID-19 vaccines for entire world: Bill Gates</a></strong></p>

<p>However, some experts also said only further trials could give a clear picture.&nbsp;</p>

<p>"Virtually any vaccine inevitably does this," Danny Altmann, a professor of immunology at the Imperial College London, said, reported Guardian, referring to the generation of antibodies and T-cells.&nbsp;</p>

<p>However, Dr Zania Stamataki, a senior lecturer in viral immunology at the University of Birmingham, said though the questions remains, the findings are a "very encouraging sign".&nbsp;</p>

<p>Some scientists have declined to comment and are waiting for the full publishing of results of the study on medical journal Lancet on Monday.&nbsp;</p>

<p>Also, experts said if the vaccine can generate immunity, the key would be to see for how long the immunity stands.</p>

<p>Recent studies have suggested that patients who have COVID-19 antibodies after getting recovered from the disease saw a signifcant fall in the number of antibodies over the three-month period.&nbsp;</p>

<p>US-based Moderna, producer of another leading COVID-19 vaccine candidate, said on Tuesday that it is all set to kick-off the final stage of human trials on July 27.&nbsp;</p>


The much-awaited COVID-19 vaccine developed by the University of Oxford has raised hopes after Phase one human trials showed some encouraging trends. Blood samples taken from a group of volunteers who were involved in the study showed the vaccine stimulated antibodies and "killer T-cells", the Daily Telegraph reported.

The much-awaited COVID-19 vaccine developed by the University of Oxford has raised hopes after Phase one human trials showed some encouraging trends. Blood samples taken from a group of volunteers who were involved in the study showed the vaccine stimulated antibodies and "killer T-cells", the Daily Telegraph reported. Also read | 8 world leaders demand equal global access to coronavirus vaccine Previous research has suggested T-cells can last in the body for years and help combat the viruses. Also read | Indian pharma industry capable of producing COVID-19 vaccines for entire world: Bill Gates However, some experts also said only further trials could give a clear picture. "Virtually any vaccine inevitably does this," Danny Altmann, a professor of immunology at the Imperial College London, said, reported Guardian, referring to the generation of antibodies and T-cells. However, Dr Zania Stamataki, a senior lecturer in viral immunology at the University of Birmingham, said though the questions remains, the findings are a "very encouraging sign". Some scientists have declined to comment and are waiting for the full publishing of results of the study on medical journal Lancet on Monday. Also, experts said if the vaccine can generate immunity, the key would be to see for how long the immunity stands. Recent studies have suggested that patients who have COVID-19 antibodies after getting recovered from the disease saw a signifcant fall in the number of antibodies over the three-month period. US-based Moderna, producer of another leading COVID-19 vaccine candidate, said on Tuesday that it is all set to kick-off the final stage of human trials on July 27.

COVID-19 vaccine: Oxford university's phase one human trials shows encouraging trends

<p>Across the world, 'Black Lives Matter' has turned into a movement, from a protest, to highlight the racism faced by the African American community, especially in the US.</p>

<p>As the movement is covering a larger ground, people are bringing down the statues of the pre and post colonial "heroes" who not only supported and promoted, but also took part in slavery and racist practices.</p>

<p>One such campaign,&nbsp;&nbsp;#RhodesMustFall started back in 2015 in South Africa, demanding the removal&nbsp;of a statue of Rhodes at Cape Town University. However, Oriel College denied the request stating the statue would be "an important reminder of the complexity of history".</p>

<p><a href="https://www.wionews.com/world/britain-removes-slave-trader-robert-milligans-statue-outside-london-museum-304708"><strong>Also read:&nbsp;Britain removes slave trader Robert Milligan's statue outside London museum</strong></a></p>
<img alt="Cecil Rhodes statue in Oriel college" data-entity-type="file" data-entity-uuid="d3735935-3154-4fb1-934b-b5801e68dfdb" src="//cdn.wionews.com/sites/default/files/inline-images/Untitled%20design%20%281%29_132.jpg" />
<p>Now, with the movement in full swing, Oriel college, an Oxford University college, has finally decided to&nbsp;remove the statue of Cecil Rhodes as it&nbsp;has been a target of anti-racism protests, though the decision would be made independently.</p>

<p>"Rhodes must fall" has been a popular slogan for the past few years now, as he is believed to have&nbsp;expressed racist beliefs and implemented racial segregation measures that started 'apartheid'.</p>

<p>Rhodes was a central figure in Britain's colonial project in Southern Africa, giving his name to Rhodesia, present-day Zimbabwe, and founding the De Beers diamond empire.</p>

<p>Officials from Oriel college will be setting up an independent&nbsp;commission of inquiry to look into the issues raised by the protestors, and will take a decision based on&nbsp;Rhodes legacy and&nbsp;college's commitment to diversity.</p>


Across the world, 'Black Lives Matter' has turned into a movement, from a protest, to highlight the racism faced by the African American community, especially in the US.

Across the world, 'Black Lives Matter' has turned into a movement, from a protest, to highlight the racism faced by the African American community, especially in the US. As the movement is covering a larger ground, people are bringing down the statues of the pre and post colonial "heroes" who not only supported and promoted, but also took part in slavery and racist practices. One such campaign, #RhodesMustFall started back in 2015 in South Africa, demanding the removal of a statue of Rhodes at Cape Town University. However, Oriel College denied the request stating the statue would be "an important reminder of the complexity of history". Also read: Britain removes slave trader Robert Milligan's statue outside London museum Now, with the movement in full swing, Oriel college, an Oxford University college, has finally decided to remove the statue of Cecil Rhodes as it has been a target of anti-racism protests, though the decision would be made independently. "Rhodes must fall" has been a popular slogan for the past few years now, as he is believed to have expressed racist beliefs and implemented racial segregation measures that started 'apartheid'. Rhodes was a central figure in Britain's colonial project in Southern Africa, giving his name to Rhodesia, present-day Zimbabwe, and founding the De Beers diamond empire. Officials from Oriel college will be setting up an independent commission of inquiry to look into the issues raised by the protestors, and will take a decision based on Rhodes legacy and college's commitment to diversity.

Oxford college wants to remove statue of colonialist Rhodes after #RhodesMustFall spreads

<p><meta charset="utf-8" /></p>

<p>The University of Oxford's COVID-19 vaccine trial has only a 50% chance of success, said Adrian Hill, director of Oxford's Jenner Institute, which has teamed up with drugmaker AstraZeneca Plc to develop the vaccine.</p>

<p>Hill said that an upcoming trial, involving 10,000 volunteers, threatened to return "no result" due to low transmission of COVID-19 in the community.</p>

<p>"It's a race against the virus disappearing, and against time", Hill told the British newspaper. "At the moment, there's a 50% chance that we get no result at all."</p>

<p>The experimental vaccine, known as ChAdOx1 nCoV-19, is one of the front-runners in the global race to provide protection against the new coronavirus which seems to be fading rapidly in Britain.</p>

<p>Hill's team began early-stage human trials of the vaccine in April, making it one of only a handful to have reached that milestone.</p>


The University of Oxford's COVID-19 vaccine trial has only a 50% chance of success, said Adrian Hill, director of Oxford's Jenner Institute, which has teamed up with drugmaker AstraZeneca Plc to develop the vaccine.

The University of Oxford's COVID-19 vaccine trial has only a 50% chance of success, said Adrian Hill, director of Oxford's Jenner Institute, which has teamed up with drugmaker AstraZeneca Plc to develop the vaccine. Hill said that an upcoming trial, involving 10,000 volunteers, threatened to return "no result" due to low transmission of COVID-19 in the community. "It's a race against the virus disappearing, and against time", Hill told the British newspaper. "At the moment, there's a 50% chance that we get no result at all." The experimental vaccine, known as ChAdOx1 nCoV-19, is one of the front-runners in the global race to provide protection against the new coronavirus which seems to be fading rapidly in Britain. Hill's team began early-stage human trials of the vaccine in April, making it one of only a handful to have reached that milestone.

Oxford's COVID-19 vaccine trial has 50% chance of success, says project leader

<p><meta name="uuid" content="uuidwpesP6hOsd63" /><meta charset="utf-8" /></p>

<p>Climate activist Greta Thunberg met Malala Yousafzai at the University of Oxford where the Nobel peace prize winner is a student.</p>

<p>22-year-old Yousafzai posted a photo on Instagram of herself and Thunberg sitting on a bench&nbsp;on Tuesday, with the caption: “Thank you, @gretathunberg” and a heart emoji.</p>

<p>17-year-old Thunberg is in the UK to join a school strike in Bristol on Friday.&nbsp;</p>

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<blockquote class="instagram-media" data-instgrm-captioned="" data-instgrm-permalink="https://www.instagram.com/p/B8_o71enY3s/?utm_source=ig_embed&amp;utm_campaign=loading" data-instgrm-version="12" style=" background:#FFF; border:0; border-radius:3px; box-shadow:0 0 1px 0 rgba(0,0,0,0.5),0 1px 10px 0 rgba(0,0,0,0.15); margin: 1px; max-width:540px; min-width:326px; padding:0; width:99.375%; width:-webkit-calc(100% - 2px); width:calc(100% - 2px);">
<div style="padding:16px;">
<div style=" display: flex; flex-direction: row; align-items: center;">
<div style="background-color: #F4F4F4; border-radius: 50%; flex-grow: 0; height: 40px; margin-right: 14px; width: 40px;">&nbsp;</div>

<div style="display: flex; flex-direction: column; flex-grow: 1; justify-content: center;">
<div style=" background-color: #F4F4F4; border-radius: 4px; flex-grow: 0; height: 14px; margin-bottom: 6px; width: 100px;">&nbsp;</div>

<div style=" background-color: #F4F4F4; border-radius: 4px; flex-grow: 0; height: 14px; width: 60px;">&nbsp;</div>
</div>
</div>

<div style="padding: 19% 0;">&nbsp;</div>

<div style="display:block; height:50px; margin:0 auto 12px; width:50px;"><a href="https://www.instagram.com/p/B8_o71enY3s/?utm_source=ig_embed&amp;utm_campaign=loading" style=" background:#FFFFFF; line-height:0; padding:0 0; text-align:center; text-decoration:none; width:100%;" target="_blank"><svg height="50px" version="1.1" viewbox="0 0 60 60" width="50px" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink"><g fill="none" fill-rule="evenodd" stroke="none" stroke-width="1"><g fill="#000000" transform="translate(-511.000000, -20.000000)"><g><path d="M556.869,30.41 C554.814,30.41 553.148,32.076 553.148,34.131 C553.148,36.186 554.814,37.852 556.869,37.852 C558.924,37.852 560.59,36.186 560.59,34.131 C560.59,32.076 558.924,30.41 556.869,30.41 M541,60.657 C535.114,60.657 530.342,55.887 530.342,50 C530.342,44.114 535.114,39.342 541,39.342 C546.887,39.342 551.658,44.114 551.658,50 C551.658,55.887 546.887,60.657 541,60.657 M541,33.886 C532.1,33.886 524.886,41.1 524.886,50 C524.886,58.899 532.1,66.113 541,66.113 C549.9,66.113 557.115,58.899 557.115,50 C557.115,41.1 549.9,33.886 541,33.886 M565.378,62.101 C565.244,65.022 564.756,66.606 564.346,67.663 C563.803,69.06 563.154,70.057 562.106,71.106 C561.058,72.155 560.06,72.803 558.662,73.347 C557.607,73.757 556.021,74.244 553.102,74.378 C549.944,74.521 548.997,74.552 541,74.552 C533.003,74.552 532.056,74.521 528.898,74.378 C525.979,74.244 524.393,73.757 523.338,73.347 C521.94,72.803 520.942,72.155 519.894,71.106 C518.846,70.057 518.197,69.06 517.654,67.663 C517.244,66.606 516.755,65.022 516.623,62.101 C516.479,58.943 516.448,57.996 516.448,50 C516.448,42.003 516.479,41.056 516.623,37.899 C516.755,34.978 517.244,33.391 517.654,32.338 C518.197,30.938 518.846,29.942 519.894,28.894 C520.942,27.846 521.94,27.196 523.338,26.654 C524.393,26.244 525.979,25.756 528.898,25.623 C532.057,25.479 533.004,25.448 541,25.448 C548.997,25.448 549.943,25.479 553.102,25.623 C556.021,25.756 557.607,26.244 558.662,26.654 C560.06,27.196 561.058,27.846 562.106,28.894 C563.154,29.942 563.803,30.938 564.346,32.338 C564.756,33.391 565.244,34.978 565.378,37.899 C565.522,41.056 565.552,42.003 565.552,50 C565.552,57.996 565.522,58.943 565.378,62.101 M570.82,37.631 C570.674,34.438 570.167,32.258 569.425,30.349 C568.659,28.377 567.633,26.702 565.965,25.035 C564.297,23.368 562.623,22.342 560.652,21.575 C558.743,20.834 556.562,20.326 553.369,20.18 C550.169,20.033 549.148,20 541,20 C532.853,20 531.831,20.033 528.631,20.18 C525.438,20.326 523.257,20.834 521.349,21.575 C519.376,22.342 517.703,23.368 516.035,25.035 C514.368,26.702 513.342,28.377 512.574,30.349 C511.834,32.258 511.326,34.438 511.181,37.631 C511.035,40.831 511,41.851 511,50 C511,58.147 511.035,59.17 511.181,62.369 C511.326,65.562 511.834,67.743 512.574,69.651 C513.342,71.625 514.368,73.296 516.035,74.965 C517.703,76.634 519.376,77.658 521.349,78.425 C523.257,79.167 525.438,79.673 528.631,79.82 C531.831,79.965 532.853,80.001 541,80.001 C549.148,80.001 550.169,79.965 553.369,79.82 C556.562,79.673 558.743,79.167 560.652,78.425 C562.623,77.658 564.297,76.634 565.965,74.965 C567.633,73.296 568.659,71.625 569.425,69.651 C570.167,67.743 570.674,65.562 570.82,62.369 C570.966,59.17 571,58.147 571,50 C571,41.851 570.966,40.831 570.82,37.631"></path></g></g></g></svg></a></div>

<div style="padding-top: 8px;">
<div style=" color:#3897f0; font-family:Arial,sans-serif; font-size:14px; font-style:normal; font-weight:550; line-height:18px;"><a href="https://www.instagram.com/p/B8_o71enY3s/?utm_source=ig_embed&amp;utm_campaign=loading" style=" background:#FFFFFF; line-height:0; padding:0 0; text-align:center; text-decoration:none; width:100%;" target="_blank">View this post on Instagram</a></div>
</div>

<div style="padding: 12.5% 0;">&nbsp;</div>

<div style="display: flex; flex-direction: row; margin-bottom: 14px; align-items: center;">
<div>
<div style="background-color: #F4F4F4; border-radius: 50%; height: 12.5px; width: 12.5px; transform: translateX(0px) translateY(7px);">&nbsp;</div>

<div style="background-color: #F4F4F4; height: 12.5px; transform: rotate(-45deg) translateX(3px) translateY(1px); width: 12.5px; flex-grow: 0; margin-right: 14px; margin-left: 2px;">&nbsp;</div>

<div style="background-color: #F4F4F4; border-radius: 50%; height: 12.5px; width: 12.5px; transform: translateX(9px) translateY(-18px);">&nbsp;</div>
</div>

<div style="margin-left: 8px;">
<div style=" background-color: #F4F4F4; border-radius: 50%; flex-grow: 0; height: 20px; width: 20px;">&nbsp;</div>

<div style=" width: 0; height: 0; border-top: 2px solid transparent; border-left: 6px solid #f4f4f4; border-bottom: 2px solid transparent; transform: translateX(16px) translateY(-4px) rotate(30deg)">&nbsp;</div>
</div>

<div style="margin-left: auto;">
<div style=" width: 0px; border-top: 8px solid #F4F4F4; border-right: 8px solid transparent; transform: translateY(16px);">&nbsp;</div>

<div style=" background-color: #F4F4F4; flex-grow: 0; height: 12px; width: 16px; transform: translateY(-4px);">&nbsp;</div>

<div style=" width: 0; height: 0; border-top: 8px solid #F4F4F4; border-left: 8px solid transparent; transform: translateY(-4px) translateX(8px);">&nbsp;</div>
</div>
</div>

<p style=" margin:8px 0 0 0; padding:0 4px;"><a href="https://www.instagram.com/p/B8_o71enY3s/?utm_source=ig_embed&amp;utm_campaign=loading" style=" color:#000; font-family:Arial,sans-serif; font-size:14px; font-style:normal; font-weight:normal; line-height:17px; text-decoration:none; word-wrap:break-word;" target="_blank">Thank you, @gretathunberg. ❤️</a></p>

<p style=" color:#c9c8cd; font-family:Arial,sans-serif; font-size:14px; line-height:17px; margin-bottom:0; margin-top:8px; overflow:hidden; padding:8px 0 7px; text-align:center; text-overflow:ellipsis; white-space:nowrap;">A post shared by <a href="https://www.instagram.com/malala/?utm_source=ig_embed&amp;utm_campaign=loading" style=" color:#c9c8cd; font-family:Arial,sans-serif; font-size:14px; font-style:normal; font-weight:normal; line-height:17px;" target="_blank"> Malala</a> (@malala) on <time datetime="2020-02-25T15:09:44+00:00" style=" font-family:Arial,sans-serif; font-size:14px; line-height:17px;">Feb 25, 2020 at 7:09am PST</time></p>
</div>
</blockquote>
<script async src="//www.instagram.com/embed.js"></script></div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

<p>Thunberg became a global icon for climate activism after striking school to take part in a protest against climate emergency while Yousafzai shot in the head while campaigning in support of girls be allowed to go&nbsp;to school.&nbsp;</p>

<p>Yousafzai became the youngest to win the noble peace prize her advocacy of education while Thunberg nominated for a Nobel Peace Prize in 2019 and 2020.</p>

<p>The duo met to discuss their activism at Lady Margaret Hall, Yousafzai’s Oxford college. Thunberg also talked to some of the students about the climate crisis and protest.</p>

<p>The college’s master, Alan Rusbridger, posted a photo of Thunberg on his own Instagram and Twitter, saying that he was honoured to host Thunberg and grateful that she found time to talk to the students.</p>

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<blockquote class="twitter-tweet">
<p dir="ltr" lang="en">Honoured to host <a href="https://twitter.com/GretaThunberg?ref_src=twsrc%5Etfw">@gretathunberg</a> at <a href="https://twitter.com/lmhoxford?ref_src=twsrc%5Etfw">@lmhoxford</a> today. grateful she found time to talk to some of our students about science, voting, the limits of protest, divestment, real zero v net zero, and much more <a href="https://t.co/FjcNEQDTci">pic.twitter.com/FjcNEQDTci</a></p>
— alan rusbridger (@arusbridger) <a href="https://twitter.com/arusbridger/status/1232342255735918593?ref_src=twsrc%5Etfw">February 25, 2020</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

<p>&nbsp;</p>


Climate activist Greta Thunberg met Malala Yousafzai at the University of Oxford where the Nobel peace prize winner is a student. 22-year-old Yousafzai posted a photo on Instagram of herself and Thunberg sitting on a bench on Tuesday, with the caption: “Thank you, @gretathunberg” and a heart emoji.

Climate activist Greta Thunberg met Malala Yousafzai at the University of Oxford where the Nobel peace prize winner is a student. 22-year-old Yousafzai posted a photo on Instagram of herself and Thunberg sitting on a bench on Tuesday, with the caption: “Thank you, @gretathunberg” and a heart emoji. 17-year-old Thunberg is in the UK to join a school strike in Bristol on Friday. View this post on Instagram Thank you, @gretathunberg. ❤️ A post shared by Malala (@malala) on Feb 25, 2020 at 7:09am PST × Thunberg became a global icon for climate activism after striking school to take part in a protest against climate emergency while Yousafzai shot in the head while campaigning in support of girls be allowed to go to school. Yousafzai became the youngest to win the noble peace prize her advocacy of education while Thunberg nominated for a Nobel Peace Prize in 2019 and 2020. The duo met to discuss their activism at Lady Margaret Hall, Yousafzai’s Oxford college. Thunberg also talked to some of the students about the climate crisis and protest. The college’s master, Alan Rusbridger, posted a photo of Thunberg on his own Instagram and Twitter, saying that he was honoured to host Thunberg and grateful that she found time to talk to the students. Honoured to host @gretathunberg at @lmhoxford today. grateful she found time to talk to some of our students about science, voting, the limits of protest, divestment, real zero v net zero, and much more pic.twitter.com/FjcNEQDTci — alan rusbridger (@arusbridger) February 25, 2020 ×

Greta Thunberg meets Malala Yousafzai at Oxford University

<p>A painting which was recently found by <a href="https://www.wionews.com/entertainment/british-rocker-ozzy-osbourne-reveals-he-has-been-diagnosed-with-parkinsons-disease-275851">British artist</a> LS Lowry was sold to a private collector for a whopping £2.65 million on Tuesday.</p>

<p>The Mill, Pendlebury was painted by LS Lowry in 1943.</p>

<p>An <a href="https://www.wionews.com/science-tech/portable-electronic-nose-to-broaden-scope-for-health-industry-1006">industrial landscape</a> in the north-west <a href="https://www.wionews.com/photos/british-royals-being-victim-of-media-invasion-275866">England </a>is depicted in the painting.</p>

<p>Like many of the artist's work, the inspiration behind it were the mills, factories, chimneys and the bustle of the industrial heartland in the countryside.</p>

<p>The first electrically powered Mill called the Acme Spinning Company Mill is depicted in this painting along with families enjoying their day out.</p>

<p>''The composition is a happy painting which ticks all the boxes as it is visually appealing and historically sound'' said Nick Orchard, head of Modern British Art at Christie's.</p>

<p>It was owned and discovered by pioneering&nbsp;<a href="https://www.wionews.com/world/hopes-for-many-battling-chronic-pain-as-scientists-discover-technique-to-silence-pain-gene-272255">DNA </a>researcher&nbsp;called Dr Leonard Hamilton who owned it for a period of 70 years.</p>

<p><img alt="Leonard D Hamilton hung the picture in his room at Oxford university" data-entity-type="file" data-entity-uuid="f2f5e17a-1882-43ad-ad01-a6060f071fb0" src="//cdn.wionews.com/sites/default/files/inline-images/Untitled%20design%20%2836%29_8.jpg" /></p>

<p>(Image courtesy: <a href="https://www.christies.com/departments/Photographs-72-1.aspx">Christie's Images Ltd</a>.)</p>

<p>He had hung it in his dorm when he studied at <a href="https://www.wionews.com/health-and-wellness/treating-cholesterol-at-an-early-stage-reduces-the-risk-of-heart-problems-study-266095">Oxford University.</a></p>

<p>He brought it along with him to the <a href="https://www.wionews.com/world/trump-tears-into-environmental-doom-mongers-at-davos-forum-275841">US </a>when he moved in 1949.</p>

<p>Nobody knew about its existence till he died in August last year.</p>


A painting which was recently found by British artist LS Lowry was sold to a private collector for a whopping £2.65 million on Tuesday. The Mill, Pendlebury was painted by LS Lowry in 1943.

A painting which was recently found by British artist LS Lowry was sold to a private collector for a whopping £2.65 million on Tuesday. The Mill, Pendlebury was painted by LS Lowry in 1943. An industrial landscape in the north-west England is depicted in the painting. Like many of the artist's work, the inspiration behind it were the mills, factories, chimneys and the bustle of the industrial heartland in the countryside. The first electrically powered Mill called the Acme Spinning Company Mill is depicted in this painting along with families enjoying their day out. ''The composition is a happy painting which ticks all the boxes as it is visually appealing and historically sound'' said Nick Orchard, head of Modern British Art at Christie's. It was owned and discovered by pioneering DNA researcher called Dr Leonard Hamilton who owned it for a period of 70 years. (Image courtesy: Christie's Images Ltd.) He had hung it in his dorm when he studied at Oxford University. He brought it along with him to the US when he moved in 1949. Nobody knew about its existence till he died in August last year.

Recently discovered British artist LS Lowry painting sold for £2.65 million

Boris Johnson was born in New York City. Johnson studied at the prestigious Oxford University. Boris worked at Times of London until he was fired. Boris was fired from Times over a fabricated quote. In 2001, Boris became a conservative member of Parliament. In 2004, he sacked for lying about an extra-marital affair. Watch this complete video to know more.

UK's New PM Boris Johnson: A Genius or A Joker?

Inside a big green bus in Afghanistan war-torn capital, dozens of children bury their heads in books, filling the air with their hushed reading voices and stringing together sentences filled with intrigue and adventure.

Library bus brings books and dreams to Afghan children

Billed as "one of the most exciting artists of our time", Ai-Da differs from generations of past masters in one inescapable way: she is a robot.

Oxford University unveil the world’s first humanoid robot artist

<p>Bollywood superstar Shah Rukh Khan on Sunday accepted Nobel laureate Malala Yousafzai's invite to speak to the students at the Oxford University.&nbsp;</p>

<p>In a reply to Yousafzai's tweet, Khan noted, "most certainly would love to do it and meeting you will be a privilege. Will put my team to schedule it sooner than soon."</p>

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<blockquote class="twitter-tweet" data-lang="en">
<p dir="ltr" lang="en">Most certainly would love to do it &amp; meeting u will be a privilege. Will put my team to schedule it sooner than soon <a href="https://t.co/hX9b0ghJxL">https://t.co/hX9b0ghJxL</a></p>
— Shah Rukh Khan (@iamsrk) <a href="https://twitter.com/iamsrk/status/1048966922480640000?ref_src=twsrc%5Etfw">October 7, 2018</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

<p>Malala Yousafzai, who has started her second academic year at the Oxford, shared a tweet from the principal of Oxford University, who had invited Shah Rukh to talk to the students at the Lady Margaret Hall.</p>

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<blockquote class="twitter-tweet" data-lang="en">
<p dir="ltr" lang="en">Still waiting!!!! <a href="https://twitter.com/iamsrk?ref_src=twsrc%5Etfw">@iamsrk</a> 🙏 <a href="https://t.co/4dof6KAFlI">https://t.co/4dof6KAFlI</a></p>
— Malala (@Malala) <a href="https://twitter.com/Malala/status/1048956362875711488?ref_src=twsrc%5Etfw">October 7, 2018</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

<p>She tagged King Khan in her tweet writing, "Still waiting! SRK."&nbsp;</p>

<p>Alan Rusbridger, principal Lady Margaret Hall, tweeted&nbsp;out asking&nbsp;if SRK could be "tempted"&nbsp;to speak to the students at&nbsp;the Oxford.&nbsp;</p>

<p>"Can we tempt you to Oxford University to talk to our students at @lmhoxford? They love you (I'm the principal)," read the tweet.&nbsp;</p>

<p><br />
&nbsp;</p>


Bollywood superstar Shah Rukh Khan on Sunday accepted Nobel laureate Malala Yousafzai's invite to speak to the students at the Oxford University. In a reply to Yousafzai's tweet, Khan noted, "most certainly would love to do it and meeting you will be a privilege.

Bollywood superstar Shah Rukh Khan on Sunday accepted Nobel laureate Malala Yousafzai's invite to speak to the students at the Oxford University. In a reply to Yousafzai's tweet, Khan noted, "most certainly would love to do it and meeting you will be a privilege. Will put my team to schedule it sooner than soon." Most certainly would love to do it & meeting u will be a privilege. Will put my team to schedule it sooner than soon https://t.co/hX9b0ghJxL — Shah Rukh Khan (@iamsrk) October 7, 2018 × Malala Yousafzai, who has started her second academic year at the Oxford, shared a tweet from the principal of Oxford University, who had invited Shah Rukh to talk to the students at the Lady Margaret Hall. Still waiting!!!! @iamsrk 🙏 https://t.co/4dof6KAFlI — Malala (@Malala) October 7, 2018 × She tagged King Khan in her tweet writing, "Still waiting! SRK." Alan Rusbridger, principal Lady Margaret Hall, tweeted out asking if SRK could be "tempted" to speak to the students at the Oxford. "Can we tempt you to Oxford University to talk to our students at @lmhoxford? They love you (I'm the principal)," read the tweet.

Meeting you will be a privilege: SRK accepts Malala's invitation to speak at Oxford 

<p>The door of the blue bus slides open and dozens of children excitedly bound up the steps, eager to get their hands on hard-to-find books in Kabul's first mobile library.</p>

<p>Named Charmaghz -- the Dari for walnut, which is associated with logic in Afghanistan because the nut resembles a brain -- the converted public bus is hard to miss as it winds through the dusty streets of the Afghan capital.</p>

<p>The library-on-wheels offers pupils and street kids free access to children's books, which are in short supply at public schools and libraries.</p>

<p>It also offers one of the few spaces outside the home that children can use in a city where fear is increasingly keeping residents behind closed doors.</p>

<p>As both the Taliban and the Islamic State group step up their attacks in Kabul, with civilians paying the price, many parents -- traumatised by the violence, some of them already devastated by loss -- have stopped taking their children out in public.</p>

<p>Charmaghz, used by as many as 300 children every day, is a rare exception.</p>

<p>The vehicle, which is rented from a state-owned bus company and takes precautions to avoid government buildings, main roads or other crowded areas targeted by militants in Kabul, is a relatively secure place for them to read, play chess and see friends.</p>

<p>"Boys, you sit in the back and girls in the front. It is important to be organised," one of three volunteers tells the children as he pulls books from an overhead shelf and places them in outstretched hands.</p>

<p>Unlike traditional libraries where chatting is discouraged, the constant hum of voices fills Charmaghz.</p>

<p>Children sit cross-legged on the carpeted floor or at desks reading aloud from some of the 600 books that have been donated by Afghan publishers.</p>

<p>"I come to the bus once a week to read books," 13-year-old Zahra told AFP.</p>

<p>"Today I'm reading about how to improve your health. I'm reading what I should do and what I should eat."</p>

<p>"When I go home I share the stories I read here with my brothers and sisters."</p>

<p>The library bus was launched in February by Oxford University graduate Freshta Karim, who has dedicated herself to improving the reading and storytelling abilities of children in Afghanistan -- an opportunity she never had as a child.</p>

<p>Karim grew up as a refugee in Pakistan and returned to Afghanistan after the fall of Taliban in 2002. She completed her undergraduate degree in Kabul before winning a Chevening scholarship to study a master's in public policy at Oxford.</p>

<p>"When we were children we did not have access to... libraries for children," Karim, 26, told AFP</p>

<p>"I remember as a kid at school we didn't even have chairs -- we were sitting on the floor to study."</p>

<p>The library bus stops at schools, parks or orphanages throughout the week, and is an "efficient" way to reach lots of children, Karim said, helping to improve Afghanistan's low general rate of literacy of just 36 percent.</p>

<p>Even now most public schools in Afghanistan do not have libraries, said Shafiullah, who used to work at Kabul's main public library and now helps non-profit organisations publish children's books.</p>

<p>"Young people and children do not have access to different types of books except their school textbooks," Shafiullah, who like many Afghans goes by one name, told AFP.</p>

<p>"And there are only a few non-governmental organisations that sometimes help publish books for children."</p>

<p>The time many children spend at schools in Afghanistan is limited.</p>

<p>Afghans receive an average of 4.6 years of formal education, according to a 2017 survey by the Asia Foundation.</p>

<p>Inside Charmaghz, 15-year-old Abbas reads to his friends the tragic story of Rostam, a hero in Persian mythology, and his son Sohrab.</p>

<p>Abbas said the library bus had given him access to books he could not find at his school.</p>

<p>"At school, you have a limited choice. You don't have a lot of books. But here you can find a whole range," he told AFP.</p>

<p>More than eight million children are enrolled in schools across Afghanistan this year, official figures show.</p>

<p>But 3.5 million other school-age kids will miss out due to school closures, grinding conflict and poverty.</p>

<p>Karim is realistic about the changes to literacy the mobile library can achieve in a country the size of Afghanistan.</p>

<p>But it is a start, said Karim, who is hoping to garner enough donations to rent another two buses.</p>

<p>"I don't think a mobile library will solve the thousands of problems that we have in our education system," she said.</p>

<p>"But a mobile library is a small effort among a lot of efforts that we have to make."</p>


The library-on-wheels offers pupils and street kids free access to children's books, which are in short supply at public schools and libraries

The door of the blue bus slides open and dozens of children excitedly bound up the steps, eager to get their hands on hard-to-find books in Kabul's first mobile library. Named Charmaghz -- the Dari for walnut, which is associated with logic in Afghanistan because the nut resembles a brain -- the converted public bus is hard to miss as it winds through the dusty streets of the Afghan capital. The library-on-wheels offers pupils and street kids free access to children's books, which are in short supply at public schools and libraries. It also offers one of the few spaces outside the home that children can use in a city where fear is increasingly keeping residents behind closed doors. As both the Taliban and the Islamic State group step up their attacks in Kabul, with civilians paying the price, many parents -- traumatised by the violence, some of them already devastated by loss -- have stopped taking their children out in public. Charmaghz, used by as many as 300 children every day, is a rare exception. The vehicle, which is rented from a state-owned bus company and takes precautions to avoid government buildings, main roads or other crowded areas targeted by militants in Kabul, is a relatively secure place for them to read, play chess and see friends. "Boys, you sit in the back and girls in the front. It is important to be organised," one of three volunteers tells the children as he pulls books from an overhead shelf and places them in outstretched hands. Unlike traditional libraries where chatting is discouraged, the constant hum of voices fills Charmaghz. Children sit cross-legged on the carpeted floor or at desks reading aloud from some of the 600 books that have been donated by Afghan publishers. "I come to the bus once a week to read books," 13-year-old Zahra told AFP. "Today I'm reading about how to improve your health. I'm reading what I should do and what I should eat." "When I go home I share the stories I read here with my brothers and sisters." The library bus was launched in February by Oxford University graduate Freshta Karim, who has dedicated herself to improving the reading and storytelling abilities of children in Afghanistan -- an opportunity she never had as a child. Karim grew up as a refugee in Pakistan and returned to Afghanistan after the fall of Taliban in 2002. She completed her undergraduate degree in Kabul before winning a Chevening scholarship to study a master's in public policy at Oxford. "When we were children we did not have access to... libraries for children," Karim, 26, told AFP "I remember as a kid at school we didn't even have chairs -- we were sitting on the floor to study." The library bus stops at schools, parks or orphanages throughout the week, and is an "efficient" way to reach lots of children, Karim said, helping to improve Afghanistan's low general rate of literacy of just 36 percent. Even now most public schools in Afghanistan do not have libraries, said Shafiullah, who used to work at Kabul's main public library and now helps non-profit organisations publish children's books. "Young people and children do not have access to different types of books except their school textbooks," Shafiullah, who like many Afghans goes by one name, told AFP. "And there are only a few non-governmental organisations that sometimes help publish books for children." The time many children spend at schools in Afghanistan is limited. Afghans receive an average of 4.6 years of formal education, according to a 2017 survey by the Asia Foundation. Inside Charmaghz, 15-year-old Abbas reads to his friends the tragic story of Rostam, a hero in Persian mythology, and his son Sohrab. Abbas said the library bus had given him access to books he could not find at his school. "At school, you have a limited choice. You don't have a lot of books. But here you can find a whole range," he told AFP. More than eight million children are enrolled in schools across Afghanistan this year, official figures show. But 3.5 million other school-age kids will miss out due to school closures, grinding conflict and poverty. Karim is realistic about the changes to literacy the mobile library can achieve in a country the size of Afghanistan. But it is a start, said Karim, who is hoping to garner enough donations to rent another two buses. "I don't think a mobile library will solve the thousands of problems that we have in our education system," she said. "But a mobile library is a small effort among a lot of efforts that we have to make."

Kabul library bus drives Afghan children to read

<p>Oxford University Press launched Salman Khurshid&#39;s new book &quot;Triple Talaq: Examining Faith&quot;, on Thursday, in New Delhi.</p>

<p>One of the most debated issues in the recent times following a landmark judgment by the Supreme Court of India, the book offers a comprehensive overview of the complicated issue and delves deeper into the other aspects of the practice. The book also brings to light the reasons and the steps taken by The Supreme Court of India to declare this form of practice unconstitutional.</p>

<p>The book launch took place in the presence of former Lt Governor of Delhi Najeeb Jung, and the author himself.</p>

<p>Besides Salman Khurshid, the book launch took place in the presence of former Lt. Governor of Delhi Najeeb Jung, former CJI Aziz Mushabber Ahmadi, National Conference (NC) president Farooq Abdullah, and Congress leaders P&nbsp;Chidambaram and Mani Shankar Aiyar.</p>

<p>Triple talaq, or talaq-e-bidat, is one of the most debated issues in the Muslim world. From antiquity, the Muslim faith has been plagued by the portrayal of Muslim men regularly misusing this perceived &quot;right&quot; to divorce their wives instantly by simply uttering &quot;talaq&quot; thrice.</p>

<p>The apex court, in the landmark judgment of Shayara Bano v&nbsp;Union of India, has taken the step to declare this form of talaq unconstitutional and to strike down its practice.</p>

<p>In &#39;Triple Talaq: Examining Faith&#39;, Salman Khurshid, intervening to offer the court an amicus brief in the &quot;Triple Talaq case&quot;, offers a straightforward yet comprehensive overview of this complicated issue. Explaining the reasons behind the court&#39;s decision, he dives deep into other aspects of this practice: why it is wrong; why it has thrived; what was the judicial history of this issue; what the Quran and Muslim religious leaders say about it; and what the comparative practices in other countries are. A handy guide to this landmark decision and what it means for Muslims in India, this book is written not just for the theologian, but also for the common reader.</p>

<p>Salman Khurshid is a senior advocate in the Supreme Court of India. He is the former Cabinet Minister of External Affairs, Law and Justice, and Corporate Affairs, Government of India. He is a celebrated author, well-known public figure, and member of the Indian National Congress.</p>

<p>Oxford University Press (OUP) is a department of the University of Oxford. It is the world&#39;s largest university press with the widest global presence. It publishes in many countries, in more than 40 languages, and in a variety of formats-print and digital.</p>

<p>Established in 1912, OUP India has grown to be one of the largest publishers in the region, with a strong presence in India and the neighbouring countries, including Nepal, Sri Lanka, and Bangladesh.&nbsp;</p>


The book offers a comprehensive overview of the complicated Triple Talaq issue and delves deeper into the other aspects of the practice

Oxford University Press launched Salman Khurshid's new book "Triple Talaq: Examining Faith", on Thursday, in New Delhi. One of the most debated issues in the recent times following a landmark judgment by the Supreme Court of India, the book offers a comprehensive overview of the complicated issue and delves deeper into the other aspects of the practice. The book also brings to light the reasons and the steps taken by The Supreme Court of India to declare this form of practice unconstitutional. The book launch took place in the presence of former Lt Governor of Delhi Najeeb Jung, and the author himself. Besides Salman Khurshid, the book launch took place in the presence of former Lt. Governor of Delhi Najeeb Jung, former CJI Aziz Mushabber Ahmadi, National Conference (NC) president Farooq Abdullah, and Congress leaders P Chidambaram and Mani Shankar Aiyar. Triple talaq, or talaq-e-bidat, is one of the most debated issues in the Muslim world. From antiquity, the Muslim faith has been plagued by the portrayal of Muslim men regularly misusing this perceived "right" to divorce their wives instantly by simply uttering "talaq" thrice. The apex court, in the landmark judgment of Shayara Bano v Union of India, has taken the step to declare this form of talaq unconstitutional and to strike down its practice. In 'Triple Talaq: Examining Faith', Salman Khurshid, intervening to offer the court an amicus brief in the "Triple Talaq case", offers a straightforward yet comprehensive overview of this complicated issue. Explaining the reasons behind the court's decision, he dives deep into other aspects of this practice: why it is wrong; why it has thrived; what was the judicial history of this issue; what the Quran and Muslim religious leaders say about it; and what the comparative practices in other countries are. A handy guide to this landmark decision and what it means for Muslims in India, this book is written not just for the theologian, but also for the common reader. Salman Khurshid is a senior advocate in the Supreme Court of India. He is the former Cabinet Minister of External Affairs, Law and Justice, and Corporate Affairs, Government of India. He is a celebrated author, well-known public figure, and member of the Indian National Congress. Oxford University Press (OUP) is a department of the University of Oxford. It is the world's largest university press with the widest global presence. It publishes in many countries, in more than 40 languages, and in a variety of formats-print and digital. Established in 1912, OUP India has grown to be one of the largest publishers in the region, with a strong presence in India and the neighbouring countries, including Nepal, Sri Lanka, and Bangladesh.

Oxford University Press launches Salman Khurshid's 'Triple Talaq: Examining Faith'

<p>A few days after <a href="http://www.wionews.com/world/rohingya-fleeing-myanmar-say-army-redoubling-push-to-clear-villages-21005">Oxford took down the portrait of Aung San Suu Kyi,</a> the University decided to stip her of the Freedom of Oxford award over her handling of the Rohingya crisis in &nbsp;Myanmar.</p>

<p>Suu Kyi is an alumnus of <a href="http://www.wionews.com/world/myanmar-beauty-queen-calls-rohingya-muslims-terrorist-organisation-stripped-of-title-20981">Oxford University having graduated in philosophy</a>, politics and economics in 1967 from St Hugh&#39;s college before completing her masters in politics in 1968.</p>

<p>The Oxford City Council voted unanimously to support a motion that said it was &quot;no longer appropriate&quot; to celebrate Suu Kyi, who has come under fierce criticism for inaction in the face of reported atrocities against Rohingya Muslims in Rakhine state, Britain&#39;s The Independent reported.</p>

<p>On Saturday, Oxford had decided to place her portrait in storage at St Hugh&#39;s college and replace it with a new painting gifted by Japanese artist Yoshihiro Takada.</p>

<p>&quot;The painting of Aung San Suu Kyi has meanwhile been moved to a secure location,&quot; the college had said in a statement.</p>

<p>Oxford&#39;s decision to strip Suu Kyi of the Freedom award and the removal of her&nbsp;1997 portrait&nbsp;comes a few days before new students arrive at the college to start their course.</p>


The Oxford City Council has voted unanimously to support a motion that said it was "no longer appropriate" to celebrate Suu Kyi

A few days after Oxford took down the portrait of Aung San Suu Kyi, the University decided to stip her of the Freedom of Oxford award over her handling of the Rohingya crisis in Myanmar. Suu Kyi is an alumnus of Oxford University having graduated in philosophy, politics and economics in 1967 from St Hugh's college before completing her masters in politics in 1968. The Oxford City Council voted unanimously to support a motion that said it was "no longer appropriate" to celebrate Suu Kyi, who has come under fierce criticism for inaction in the face of reported atrocities against Rohingya Muslims in Rakhine state, Britain's The Independent reported. On Saturday, Oxford had decided to place her portrait in storage at St Hugh's college and replace it with a new painting gifted by Japanese artist Yoshihiro Takada. "The painting of Aung San Suu Kyi has meanwhile been moved to a secure location," the college had said in a statement. Oxford's decision to strip Suu Kyi of the Freedom award and the removal of her 1997 portrait comes a few days before new students arrive at the college to start their course.

Suu Kyi stripped of Freedom of Oxford award amid Rohingya crisis

<p>Nobel Peace Prize laureate Malala Yousafzai will study Philosophy,&nbsp;Politics, and Economics at the prestigious Oxford University.</p>

<p>The 20-year-old from Pakistan who was shot at by Taliban for her campaign to promote education among girls tweeted the confirmation received by her from the University.</p>

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<blockquote class="twitter-tweet" data-lang="en">
<p dir="ltr" lang="en">So excited to go to Oxford!! Well done to all A-level students - the hardest year. Best wishes for life ahead! <a href="https://t.co/miIwK6fNSf">pic.twitter.com/miIwK6fNSf</a></p>
&mdash; Malala (@Malala) <a href="https://twitter.com/Malala/status/898083175213260800">August 17, 2017</a></blockquote>
<script async src="//platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<a class="close-mark close-div" href="#" id="jqclosemark">&times;</a></div>

<p>She got the admission after securing three As at the A-level. In March, Malala&nbsp;had said that she would enter a UK college to study politics, philosophy, and economics after getting three As at the A-level.</p>

<p>Malala&#39;s father expressed his happiness at the news of his daughter studying at the Oxford University.</p>

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<blockquote class="twitter-tweet" data-lang="en">
<p dir="ltr" lang="en">My heart is full of gratitude. We are grateful to Allah &amp; thank u 2 al those who support <a href="https://twitter.com/Malala">@Malala</a> 4 the grand cause of education <a href="https://twitter.com/MalalaFund">@MalalaFund</a> <a href="https://t.co/Cgro6vpPXV">https://t.co/Cgro6vpPXV</a></p>
&mdash; Ziauddin Yousafzai (@ZiauddinY) <a href="https://twitter.com/ZiauddinY/status/898088927915061248">August 17, 2017</a></blockquote>
<script async src="//platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<a class="close-mark close-div" href="#" id="jqclosemark">&times;</a></div>

<p>Malala will study the same course at the same college attended by former Pakistani Prime Minister Benazir Bhutto and a host of other world leaders.</p>

<p>&nbsp;</p>

<p>&nbsp;</p>


The 20-year-old from Pakistan was shot by the Taliban for her campaign to promote education among girls

Nobel Peace Prize laureate Malala Yousafzai will study Philosophy, Politics, and Economics at the prestigious Oxford University. The 20-year-old from Pakistan who was shot at by Taliban for her campaign to promote education among girls tweeted the confirmation received by her from the University. So excited to go to Oxford!! Well done to all A-level students - the hardest year. Best wishes for life ahead! pic.twitter.com/miIwK6fNSf — Malala (@Malala) August 17, 2017 × She got the admission after securing three As at the A-level. In March, Malala had said that she would enter a UK college to study politics, philosophy, and economics after getting three As at the A-level. Malala's father expressed his happiness at the news of his daughter studying at the Oxford University. My heart is full of gratitude. We are grateful to Allah & thank u 2 al those who support @Malala 4 the grand cause of education @MalalaFund https://t.co/Cgro6vpPXV — Ziauddin Yousafzai (@ZiauddinY) August 17, 2017 × Malala will study the same course at the same college attended by former Pakistani Prime Minister Benazir Bhutto and a host of other world leaders.

Malala Yousafzai to go to Oxford, study same course as Benazir

<p>Oxford University wants students to use the gender neutral &quot;ze&quot; instead of &quot;he&quot; or &quot;she&quot; when addressing fellow students.</p>

<p>One of the world&#39;s leading educational institutions has outlined the new guidelines in a students&#39; union leaflet as part of a move to prevent transgender students being offended, <a href="http://www.thetimes.co.uk/edition/news/he-and-she-are-now-ze-at-oxford-3kb33jtp8">The Sunday Times</a> reported.</p>

<p>Deliberately using the wrong pronoun for a transgender person is already an offence under Oxford&#39;s behaviour code.</p>

<p>In a move set to be imposed at Cambridge University too, students hope the use of gender neutral pronouns will be extended to lectures and seminars.</p>

<p>&quot;Gender neutral pronouns are good...It should happen in lectures, too,&quot; said Franky Sissons, a transgender student at King&#39;s College, University of Cambridge.</p>

<p>Last month,&nbsp;one of&nbsp;Oxford&#39;s 38 colleges became one of the first to introduce gender-neutral lavatories marked with a new symbol.</p>

<p>St Catherine&#39;s College, which hopes the move will be replicated across the university, unveiled the new lavatories with a sign combining the familiar scientific symbols for male and female.<br />
<br />
(PTI)</p>


Oxford students will use 'ze' while addressing each other move to prevent transgender students being offended

Oxford University wants students to use the gender neutral "ze" instead of "he" or "she" when addressing fellow students. One of the world's leading educational institutions has outlined the new guidelines in a students' union leaflet as part of a move to prevent transgender students being offended, The Sunday Times reported. Deliberately using the wrong pronoun for a transgender person is already an offence under Oxford's behaviour code. In a move set to be imposed at Cambridge University too, students hope the use of gender neutral pronouns will be extended to lectures and seminars. "Gender neutral pronouns are good...It should happen in lectures, too," said Franky Sissons, a transgender student at King's College, University of Cambridge. Last month, one of Oxford's 38 colleges became one of the first to introduce gender-neutral lavatories marked with a new symbol. St Catherine's College, which hopes the move will be replicated across the university, unveiled the new lavatories with a sign combining the familiar scientific symbols for male and female. (PTI)

Oxford University students to use gender neutral 'ze' instead of he or she

oxford-university

Oxford University, News on Oxford University, stories on Oxford University, articles on Oxford University, Oxford University stories at Wion, Oxford University news, Oxford University latest news

oxford university